Our Vision
Screening for breast cancer
with a blood sample.
Innovative Biomarker Approach
In several recent scientific papers it is suggested, that certain blood biomarkers may be useful to identify early signs of breast cancer.
Detecting cancer-specific biomarkers in the patient's blood combined with AI leeds to early intervention, increasing the chances of successful treatment.
Simple, Non-Invasive Process
Our radiation-free AI-powered analysis, using just a blood sample, delivers an output for which our scientifc work suggests it is correlated with breast cancer presence.
Early Intervention
The entire analysis process aims to take 2 weeks, from the arrival of the blood sample at the specialised earlytrace laboratory to the availability of the result.
Marc Mausch
Physicist, currently working at the University Hospital of Tübingen at the Research Group of Methods of Medical Informatics. He has more than 20 years of technology business experience across several industries, and successfully founded and established a Telemed company.
Julia Wagner
Holds an MA in Organizational Development and Human Resources and is the head of the Digital Customer Services Channels unit of one of the five biggest German public health insurances. During the pandemic, she worked at the Baden-Württemberg Ministry of Health to support with her deep healthcare organization knowledge.
References
1- for Europe only source: Institutional agency for research cancer (WHO). https://gco.iarc.fr/today/en/dataviz/maps-heatmap?mode=population&cancers=20&zoom=5
2- Europe only. EE is leading with 51%, and SE = 31%. Int J Cancer. 2021 Jan 15; 148(2): 406–418. Published online 2020 Jul 30. doi: 10.1002/ijc.3320 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754503/
3- Europe only with 100% coverage, 12 434 additional breast cancer deaths could be prevented annually. source: PubMed- www.ncbi.nlm.nih